AMRK vs BIIB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRK is a Hold and BIIB is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMRK’s FA Score shows that 2 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).
- AMRK’s FA Score: 2 green, 3 red.
- BIIB’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMRK’s TA Score shows that 5 TA indicator(s) are bullish while BIIB’s TA Score has 5 bullish TA indicator(s).
- AMRK’s TA Score: 5 bullish, 5 bearish.
- BIIB’s TA Score: 5 bullish, 4 bearish.
Price Growth
AMRK (@Investment Banks/Brokers) experienced а -3.35% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +1.19% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +1.49%. For the same industry, the average monthly price growth was +2.24%, and the average quarterly price growth was +109.84%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.38%. For the same industry, the average monthly price growth was +2.02%, and the average quarterly price growth was -6.49%.
Reported Earning Dates
AMRK is expected to report earnings on Aug 28, 2025.
BIIB is expected to report earnings on Jul 23, 2025.
Industries' Descriptions
@Investment Banks/Brokers (+1.49% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
@Pharmaceuticals: Major (+1.38% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| AMRK | BIIB | AMRK / BIIB | |
| Capitalization | 701M | 31.3B | 2% |
| EBITDA | 194M | 2.04B | 10% |
| Gain YTD | -10.174 | -20.919 | 49% |
| P/E Ratio | 6.82 | 26.95 | 25% |
| Revenue | 10B | 9.84B | 102% |
| Total Cash | 28.5M | 1.05B | 3% |
| Total Debt | 824M | 7.34B | 11% |
AMRK | BIIB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 3 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 27 Undervalued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 47 | 100 | |
SMR RATING 1..100 | 70 | 67 | |
PRICE GROWTH RATING 1..100 | 81 | 64 | |
P/E GROWTH RATING 1..100 | 23 | 96 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMRK's Valuation (27) in the Investment Banks Or Brokers industry is somewhat better than the same rating for BIIB (87) in the Biotechnology industry. This means that AMRK’s stock grew somewhat faster than BIIB’s over the last 12 months.
AMRK's Profit vs Risk Rating (47) in the Investment Banks Or Brokers industry is somewhat better than the same rating for BIIB (100) in the Biotechnology industry. This means that AMRK’s stock grew somewhat faster than BIIB’s over the last 12 months.
BIIB's SMR Rating (67) in the Biotechnology industry is in the same range as AMRK (70) in the Investment Banks Or Brokers industry. This means that BIIB’s stock grew similarly to AMRK’s over the last 12 months.
BIIB's Price Growth Rating (64) in the Biotechnology industry is in the same range as AMRK (81) in the Investment Banks Or Brokers industry. This means that BIIB’s stock grew similarly to AMRK’s over the last 12 months.
AMRK's P/E Growth Rating (23) in the Investment Banks Or Brokers industry is significantly better than the same rating for BIIB (96) in the Biotechnology industry. This means that AMRK’s stock grew significantly faster than BIIB’s over the last 12 months.
| AMRK | BIIB | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 58% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 48% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 70% |
| Advances ODDS (%) | 9 days ago 82% | 3 days ago 53% |
| Declines ODDS (%) | 4 days ago 75% | 17 days ago 69% |
| BollingerBands ODDS (%) | 2 days ago 88% | 2 days ago 59% |
| Aroon ODDS (%) | 2 days ago 73% | 2 days ago 69% |
AMRK and
Correlation & Price change
A.I.dvisor tells us that AMRK and NMR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRK and NMR's prices will move in lockstep.
| Ticker / NAME | Correlation To AMRK | 1D Price Change % | ||
|---|---|---|---|---|
| AMRK | 100% | -0.57% | ||
| NMR - AMRK | 32% Poorly correlated | -0.72% | ||
| SNEX - AMRK | 31% Poorly correlated | +1.55% | ||
| PIPR - AMRK | 30% Poorly correlated | +0.70% | ||
| TREE - AMRK | 30% Poorly correlated | +4.90% | ||
| LAZ - AMRK | 30% Poorly correlated | +1.34% | ||
More | ||||